Market Capitalization of Bafna Pharmaceuticals (BAFNAPH)
As of June 8, 2026, Bafna Pharmaceuticals (BAFNAPH) market capitalisation is ₹483.56 Cr ($53.73M), with 2.49 Cr shares outstanding at a current price of ₹193.97 on NSE, ranking 1924 out of 5363 companies by market cap in our screener. Bafna Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. View Bafna Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
Market Cap History of Bafna Pharmaceuticals (Last 10 Years)
BAFNAPH market capitalisation from year-end NSE closing prices over the last 10 years. Compare with BAFNAPH stock valuation models to assess whether the stock is under or overvalued.
End of Year Market Cap History — Bafna Pharmaceuticals
BAFNAPH year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Bafna Pharmaceuticals share price chart.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹483.56 Cr
$53.73M USD
|
₹193.97 | NSE | +64.37% |
| 2025 |
₹294.19 Cr
$32.69M USD
|
₹118.01 | NSE | +49.57% |
| 2024 |
₹196.69 Cr
$21.85M USD
|
₹78.90 | NSE | -14.24% |
| 2023 |
₹229.35 Cr
$25.48M USD
|
₹92.00 | NSE | -8.68% |
| 2022 |
₹251.17 Cr
$27.91M USD
|
₹100.75 | NSE | -33.96% |
| 2021 |
₹380.30 Cr
$42.26M USD
|
₹152.55 | NSE | -10.71% |
| 2020 |
₹425.92 Cr
$47.32M USD
|
₹170.85 | NSE | - |